These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2211593)

  • 1. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
    Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
    J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
    Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
    Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
    Nakagaki T; Foster DC; Berkner KL; Kisiel W
    Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.
    Rao LV; Rapaport SI
    Blood; 1987 Feb; 69(2):645-51. PubMed ID: 3492226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa.
    Kazama Y; Pastuszyn A; Wildgoose P; Hamamoto T; Kisiel W
    J Biol Chem; 1993 Aug; 268(22):16231-40. PubMed ID: 8344908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
    Yamamoto M; Nakagaki T; Kisiel W
    J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
    van 't Veer C; Golden NJ; Kalafatis M; Mann KG
    J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
    Bjoern S; Foster DC; Thim L; Wiberg FC; Christensen M; Komiyama Y; Pedersen AH; Kisiel W
    J Biol Chem; 1991 Jun; 266(17):11051-7. PubMed ID: 1904059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
    Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
    J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.